Evidence map›Paper›PMID 41978265›Full record

ArticleNucleic acids research2026

Nuclear speckle dynamics are controlled by polyphosphate inhibition of CLK proteins.

Blanca Lázaro, Francisco J Tadeo, Andrea Rodríguez, Lucía Ayuso-Molina, Joan Marc Martínez-Láinez, Eva Quandt, Maribel Bernard, Filipy Borghi, Adolfo Saiardi, Jonàs Juan-Mateu and 3 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Blanca LázaroDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona 08195, Spain.
Francisco J TadeoDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona 08195, Spain.ORCID 0000-0002-6018-1427
Andrea RodríguezDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona 08195, Spain.
Lucía Ayuso-MolinaDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona 08195, Spain.
Joan Marc Martínez-LáinezDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona 08195, Spain.
Eva QuandtDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona 08195, Spain.
Maribel BernardDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona 08195, Spain.
Filipy BorghiLaboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom.ORCID 0000-0001-5132-9031
Adolfo SaiardiLaboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom.ORCID 0000-0002-4351-0081
Jonàs Juan-MateuDepartment of Medicine and Life Sciences, Faculty of Health and Life Sciences, Universitat Pompeu Fabra, Barcelona 08003, Spain.
Javier JiménezDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona 08195, Spain.ORCID 0000-0002-0402-4427
Josep ClotetDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona 08195, Spain.
Samuel BruDepartment of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona 08195, Spain.

Funding

Ministerio de Ciencia e InnovaciónSpanish Government PID2021-127302NB-I00Spanish Government PID2024-158824NB-I00Universitat Internacional de Catalunya
6 · The paper itself

Abstract

Nuclear speckles (NS) are membraneless nuclear organelles that act as critical hubs for pre-messenger RNA splicing. Defects in splicing are linked to several human diseases, including cancer, Alzheimer's disease, and dystrophies. While CLK kinases regulate the mobilization of splicing factors from NS, the molecular mechanisms underlying NS assembly and dissolution remain unclear. Using an adaptation of the Biotinylation by Antibody Recognition technique, we identified polyphosphate (polyP) as a novel and essential regulator of NS dynamics. Polyphosphate, a highly conserved polyanion composed of a chain of phosphate molecules, is involved in several functions in mammalian cells. Here, we show that polyP interacts with the NS core component SRRM2, and its depletion disrupts NS organization releasing splicing factors into the nucleoplasm. RNA-seq analysis reveals that polyP depletion increases exon exclusion, particularly in transcripts with multiple isoforms, highlighting its role in splicing regulation. Mechanistically, we demonstrate that polyP acts as a physiological inhibitor of CLK3 kinase, preventing the phosphorylation of SR proteins and thereby maintaining NS stability. Our findings not only expand our understanding of NS biology but also provide new insights into the polyP involvement in splicing-related diseases.

Indexed as

Nuclear SpecklesPolyphosphatesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesAnimalsCell NucleusHeLa CellsHumansPhosphorylationRNA-Binding ProteinsRNA SplicingSerine-Arginine Splicing FactorsClk dual-specificity kinasesPolyphosphatesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesRNA-Binding ProteinsSerine-Arginine Splicing Factors

Identifiers

PMID41978265
PMCPMC13076214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.